Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Higher cannabis use may be linked to more severe hair loss.

Eczema patients have a lower skin lipid to protein ratio, older and longer-staying hospital patients are more likely to get pressure ulcers, hair loss in AGA is linked to muscle degeneration, vitamin D deficiency is common in alopecia areata and linked to its severity, standard liver tests don't effectively detect fibrosis in psoriasis patients on methotrexate, and bullous pemphigoid patients have a higher death risk but combination therapy may reduce it.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Obesity is strongly linked to the severity of hirsutism in women.

COVID-19 often causes hair loss, especially in women.

Oral minoxidil significantly reduces hair shedding in women with chronic telogen effluvium.

Unani medicine effectively reduced hair loss in a 24-year-old woman without side effects.

Trichoscopy is a quick, cost-effective tool for diagnosing different hair loss conditions.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

COVID-19 can cause different skin issues, including rashes and hair loss.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

New understanding and treatments for hair loss are improving, but more research is needed.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

COVID-19 vaccination may slightly increase the risk of hair loss, but benefits outweigh this risk.

COVID-19 may affect hair loss, but more research is needed.